Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Sep;1(5):590–596. doi: 10.1128/cdli.1.5.590-596.1994

DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease.

D F Friedman 1, P Kwittken 1, B Cizman 1, E Argyris 1, J Kearns 1, S Y Yang 1, C Zmijewski 1, N Bunin 1, S D Douglas 1, D Monos 1
PMCID: PMC368345  PMID: 8556506

Abstract

Transfusion-associated graft-versus-host disease (TAGVHD) is a rare and usually fatal complication of blood transfusion which can arise when immunocompetent lymphocytes from the donor of a cellular blood product are transfused into a severely immunocompromised recipient. We describe the case of an 8-month-old male with a severe combined immunodeficiency syndrome who developed TAGVHD after receiving an unirradiated transfusion. Serologic HLA typing of the parents, the patient, and the blood donor demonstrated the foreign origin of circulating lymphocytes, confirming the diagnosis of TAGVHD. The manifestations of TAGVHD did not respond to medical immunosuppressive therapy, and bone marrow transplantation was planned to treat the underlying immunodeficiency as well as the TAGVHD. By using DNA-based class I and class II HLA typing, the child's HLA type was determined from nonhematopoietic tissues. This information proved critical in selecting the bone marrow donor. The child received immunosuppression, myeloablation, and a T-depleted, maternal bone marrow graft mismatched at one HLA class II allele. Trilineage hematopoietic engraftment occurred within 3 weeks, and the child remains clinically stable with no evidence of TAGVHD more than 2 years after the transplant. This case illustrates that TAGVHD can be successfully treated by allogeneic bone marrow transplantation and that DNA-based HLA typing can play a unique role in the diagnosis and management of TAGVHD.

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Weinstein H. J. Transfusion-associated graft-versus-host disease. N Engl J Med. 1990 Aug 2;323(5):315–321. doi: 10.1056/NEJM199008023230506. [DOI] [PubMed] [Google Scholar]
  2. Arredondo-Vega F. X., Kurtzberg J., Chaffee S., Santisteban I., Reisner E., Povey M. S., Hershfield M. S. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency. J Clin Invest. 1990 Aug;86(2):444–452. doi: 10.1172/JCI114730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blundell E. L., Pamphilon D. H., Anderson N. A., Slade R. R., Burton P. A., Martin A., Ray T., Bradley B. A., Lawler M., Humphries P. Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR. Br J Haematol. 1992 Nov;82(3):622–623. doi: 10.1111/j.1365-2141.1992.tb06479.x. [DOI] [PubMed] [Google Scholar]
  4. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T. Nomenclature for factors of the HLA system, 1991. Immunobiology. 1993 Jan;187(1-2):51–69. doi: 10.1016/S0171-2985(11)80245-7. [DOI] [PubMed] [Google Scholar]
  5. Capon S. M., DePond W. D., Tyan D. B., Pepkowitz S. H., Toyoda H., Cinman A. C., Azer P. C., Goldfinger D. Transfusion-associated graft-versus-host disease in an immunocompetent patient. Ann Intern Med. 1991 Jun 15;114(12):1025–1026. doi: 10.7326/0003-4819-114-12-1025. [DOI] [PubMed] [Google Scholar]
  6. Conley M. E., Lavoie A., Briggs C., Brown P., Guerra C., Puck J. M. Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1988 May;85(9):3090–3094. doi: 10.1073/pnas.85.9.3090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Conley M. E., Nowell P. C., Henle G., Douglas S. D. XX T cells and XY B cells in two patients with severe combined immune deficiency. Clin Immunol Immunopathol. 1984 Apr;31(1):87–95. doi: 10.1016/0090-1229(84)90192-2. [DOI] [PubMed] [Google Scholar]
  8. Drobyski W., Thibodeau S., Truitt R. L., Baxter-Lowe L. A., Gorski J., Jenkins R., Gottschall J., Ash R. C. Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood. 1989 Nov 1;74(6):2285–2294. [PubMed] [Google Scholar]
  9. Hansen J. A., Good R. A., Dupont B. HLA-D compatibility between parent and child: increased occurrence in severe combined immunodeficiency and other hematopoietic diseases. Transplantation. 1977 Apr;23(4):366–374. doi: 10.1097/00007890-197704000-00011. [DOI] [PubMed] [Google Scholar]
  10. Knobloch C., Goldmann S. F., Lattke H., Friedrich W. Stable engraftment of allogeneic T lymphocytes in a patient with severe combined immunodeficiency following a transfusion with unirradiated blood. Specific recognition of host histocompatibility antigens and engraftment failure of a bone marrow transplant HLA-identical to the host. Transplantation. 1991 Apr;51(4):818–824. doi: 10.1097/00007890-199104000-00016. [DOI] [PubMed] [Google Scholar]
  11. Kunstmann E., Bocker T., Roewer L., Sauer H., Mempel W., Epplen J. T. Diagnosis of transfusion-associated graft-versus-host disease by genetic fingerprinting and polymerase chain reaction. Transfusion. 1992 Oct;32(8):766–770. doi: 10.1046/j.1537-2995.1992.32893032108.x. [DOI] [PubMed] [Google Scholar]
  12. Landay A. L., Muirhead K. A. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin Immunol Immunopathol. 1989 Jul;52(1):48–60. doi: 10.1016/0090-1229(89)90192-x. [DOI] [PubMed] [Google Scholar]
  13. Le Deist F., Raffoux C., Griscelli C., Fischer A. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol. 1987 Jan 15;138(2):423–427. [PubMed] [Google Scholar]
  14. Leitman S. F., Holland P. V. Irradiation of blood products. Indications and guidelines. Transfusion. 1985 Jul-Aug;25(4):293–303. doi: 10.1046/j.1537-2995.1985.25485273804.x. [DOI] [PubMed] [Google Scholar]
  15. Matsushita H., Shibata Y., Fuse K., Kimura M., Iinuma K. Sex chromatin analysis of lymphocytes invading host organs in transfusion-associated graft-versus-host disease. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;55(4):237–239. doi: 10.1007/BF02896581. [DOI] [PubMed] [Google Scholar]
  16. Niethammer D., Goldmann S. F., Flad H. D., Bienzle U., Dieterle U., Haas R. J., Heymer B., Meigel W., Belohradsky B. H., Kleihauer E. Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion. Clin Immunol Immunopathol. 1981 Mar;18(3):387–401. doi: 10.1016/0090-1229(81)90132-x. [DOI] [PubMed] [Google Scholar]
  17. Oh S. H., Fleischhauer K., Yang S. Y. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens. 1993 Mar;41(3):135–142. doi: 10.1111/j.1399-0039.1993.tb01992.x. [DOI] [PubMed] [Google Scholar]
  18. Pollack M. S., Kirkpatrick D., Kapoor N., Dupont B., O'Reilly R. J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982 Sep 9;307(11):662–666. doi: 10.1056/NEJM198209093071106. [DOI] [PubMed] [Google Scholar]
  19. Puck J. M., Krauss C. M., Puck S. M., Buckley R. H., Conley M. E. Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med. 1990 Apr 12;322(15):1063–1066. doi: 10.1056/NEJM199004123221508. [DOI] [PubMed] [Google Scholar]
  20. Rappeport J. M. Transfusion-associated graft-versus-host disease. Yale J Biol Med. 1990 Sep-Oct;63(5):445–454. [PMC free article] [PubMed] [Google Scholar]
  21. Rubinstein A., Rádl J., Cottier H., Rossi E., Gugler E. Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gutimmunity and graft-versus-host reaction after plasma infusion. Acta Paediatr Scand. 1973 Jul;62(4):365–372. doi: 10.1111/j.1651-2227.1973.tb08121.x. [DOI] [PubMed] [Google Scholar]
  22. Thaler M., Shamiss A., Orgad S., Huszar M., Nussinovitch N., Meisel S., Gazit E., Lavee J., Smolinsky A. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med. 1989 Jul 6;321(1):25–28. doi: 10.1056/NEJM198907063210105. [DOI] [PubMed] [Google Scholar]
  23. Thompson L. F., O'Connor R. D., Bastian J. F. Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency. J Immunol. 1984 Nov;133(5):2513–2517. [PubMed] [Google Scholar]
  24. Wang L., Juji T., Tokunaga K., Takahashi K., Kuwata S., Uchida S., Tadokoro K., Takai K. Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease. N Engl J Med. 1994 Feb 10;330(6):398–401. doi: 10.1056/NEJM199402103300605. [DOI] [PubMed] [Google Scholar]
  25. Yoshida M., Kimura A., Numano F., Sasazuki T. Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B gene. Hum Immunol. 1992 Aug;34(4):257–266. doi: 10.1016/0198-8859(92)90025-i. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES